PMID: 7015884May 1, 1981Paper

Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients

The American Journal of Psychiatry
M H BrancheyM A Richardson

Abstract

The authors decreased neuroleptic medication in 21 chronic schizophrenic patients in an attempt to minimize the risks of tardive dyskinesia. Level of psychopathology and severity of dyskinetic symptoms were monitored while the neuroleptic was gradually decreased over 3 months and then discontinued. Only 1 patient relapsed during drug decrease; however, 15 patients relapsed within 6 months after drug withdrawal. After relapse, medication was gradually increased. The doses needed to induce recovery were higher than those which had been sufficient to prevent relapse during gradual drug reduction. Dyskinetic symptoms were not significantly modified during drug reduction but increased significantly after drug discontinuation.

Citations

Jul 1, 1991·Schizophrenia Research·W F Hoffman, D E Casey
Jan 1, 1990·Acta Psychiatrica Scandinavica. Supplementum·J RosenS Gershon
Feb 7, 2018·The Cochrane Database of Systematic Reviews·Hanna BergmanKarla Soares-Weiser
May 18, 2012·The Cochrane Database of Systematic Reviews·Stefan LeuchtJohn M Davis
May 12, 2018·The Cochrane Database of Systematic Reviews·Myrto T SamaraStefan Leucht
Jan 1, 1990·International Journal of Psychiatry in Medicine·J J StrainJ J Strain
Oct 10, 2018·Journal of Clinical Psychopharmacology·Hideaki TaniHiroyuki Uchida
Jan 27, 2006·The Cochrane Database of Systematic Reviews·K Soares-Weiser, J Rathbone
Jul 1, 1996·Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees·A E Shamoo, T J Keay
Oct 19, 2007·The Cochrane Database of Systematic Reviews·A ChakrabartiJ Xia
Apr 19, 2000·Journal of Clinical Psychopharmacology·J VolavkaN Bark
Mar 1, 1986·Alcoholism, Clinical and Experimental Research·M J Eckardt, P R Martin
Aug 26, 2020·The Cochrane Database of Systematic Reviews·Anna CerasoStefan Leucht
Feb 1, 1990·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·G LeblancC Gingras
Feb 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·J F MacMillanE C Johnstone
May 1, 1994·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·G LeblancS Vaillancourt
Oct 1, 1993·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M A GagnéT Di Paolo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here